Project Grant S10OD040282
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a $471,712 Project Grant from the National Institutes of Health (NIH) Office of the Director under the Research Infrastructure Programs (CFDA 93.351) to acquire a BIACORE 1S+ Surface Plasmon Resonance (SPR) instrument manufactured by Cytiva. The award, effective June 1, 2026, through May 31, 2027, will provide the institution with critical analytical infrastructure for detecting and characterizing...
- Federal Project Grant Award Summary The National Institutes of Health (NIH) Office of the Director awarded $1.00 through the Research Infrastructure Programs (CFDA 93.351) to the University of Texas Health Science Center at San Antonio on July 15, 2025, with a completion date of July 14, 2026. The grant funds the acquisition and installation of a 10X Genomics Xenium Analyzer, a high-resolution spatial transcriptomics and proteomics instrument to be housed in the Genome Sequencing Facility...
- Federal Project Grant Award Summary The University of Texas Medical Branch at Galveston received a $1,112,821 Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866) awarded January 1, 2026, with a completion date of December 31, 2030. This research initiative investigates the interplay between microglia and tau oligomer polymorphs in cognitive resilience among Alzheimer's disease patients. The project focuses on understanding why certain individuals...
- Federal Grant Award Summary The University of Texas Health Science Center at San Antonio received a $385,639 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through June 30, 2030. The award funds basic biomedical research investigating the molecular architecture and function of synaptic AMPA (A-amino-3-hydroxy-5-methyl-4-isoxazolepropionic) receptor complexes. The...
- Federal Project Grant Award Summary The University of Texas Health Science Center at Houston received a $390,000 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective March 1, 2026 through December 31, 2030. This award supports fundamental biomedical research investigating inter-organelle unfolded protein response (UPR) coordination and cellular proteostasis. The project examines...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a $1.476 million Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) effective September 1, 2025, through August 31, 2028. The award supports fundamental research investigating molecular networks in RNA homeostasis and their relationship to neuromuscular diseases, with particular focus on understanding...
- Federal Grant Award Summary The University of Texas Health Science Center at San Antonio received a $346,350 Project Grant from the National Institutes of Health (NIH) Office of the Director under the Research Infrastructure Programs (CFDA 93.351) to install a helium capture and reliquification system for its Nuclear Magnetic Resonance (NMR) facility. The award, obligated on August 1, 2025, with a completion date of July 31, 2026, funds site preparation and installation of equipment designed...
- Federal Grant Award Summary The University of Texas Health Science Center at Houston received a $643,576 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310), effective September 15, 2025, with a completion date of July 31, 2029. This award funds the design and development of the Perioperative Organ Injury Knowledge Base (POI-KB), an innovative digital platform designed to systematically catalog and...
- Federal Project Grant Award Summary The National Institutes of Health (NIH) Office of the Director awarded $750,000 to the University of Texas Health Science Center at San Antonio under the Research Infrastructure Programs (CFDA 93.351) to acquire an Illumina NovaSeq X sequencing system for the Genome Sequencing Facility (GSF) at the Greehey Children's Cancer Research Institute. The award, obligated on May 15, 2026, with a completion date of May 14, 2027, will provide high-throughput genomic...
- Federal Grant Award Summary The University of Texas Southwestern Medical Center received a $3.18 million Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), awarded August 13, 2025, with completion targeted for July 31, 2029. This award supports research investigating the spatial organization and conformational ensembles of alpha-synuclein (α-syn) amyloids within cellular environments. The project delivers scientific research products...
The University of Texas Medical Branch at Galveston received a $338,463 Project Grant from the National Institutes of Health Office of the Director under the Research Infrastructure Programs (CFDA 93.351) to acquire a state-of-the-art High-Performance Liquid Chromatography (HPLC) system. The award, obligated on May 15, 2026, with a completion date of May 14, 2027, will support the production of high-quality, standardized soluble protein aggregates associated with Alzheimer's Disease (AD) and Alzheimer's Disease Related Dementias (ADRD), including tau aggregates. This instrumentation will serve researchers at the Mitchell Center for Neurodegenerative Diseases and the broader research community nationwide. The HPLC system will enable rigorous standardization of protein aggregate preparations from tissues and cells, addressing a critical gap in current research capabilities. By providing rigorously characterized protein aggregates, the equipment will facilitate investigations into the molecular basis of disease pathogenesis and support the development of novel diagnostic and therapeutic strategies tailored to specific protein aggregate polymorphs. The acquisition aligns with the Research Infrastructure Programs' focus on supporting specialized scientific instrumentation essential to advancing the biomedical research enterprise.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $338.5k | 5/22/26 |